首页> 外文期刊>JAMA: the Journal of the American Medical Association >Lipid parameters and cardiovascular events in patients taking statins - Reply
【24h】

Lipid parameters and cardiovascular events in patients taking statins - Reply

机译:服用他汀类患者的脂质参数和心血管事件 - 答复

获取原文
获取原文并翻译 | 示例
           

摘要

Drs Martin and Jones agree with us that individuals reaching their LDL-C target but not their non-HDL-C target are at increased cardiovascular risk, whereas the opposite was not the case. They requested 2 additional analyses. People reaching the LDL-C target of 70 mg/dL but not the non-HDL-C target of 100 mg/dL were not at increased cardiovascular risk (HR, 1.05; 95% CI, 0.88-1.26) compared with those reaching both targets. The same is true for those reaching the non-HDL-C but not the LDL-C target (HR, 0.93; 95% CI, 0.82-1.05). A similar analysis using the LDL-C target of 100 mg/dL and the apoB target of 80 mg/ dL, as suggested by Contois et al, yielded slightly different results. Those reaching the LDL-C but not the apoB target were at increased cardiovascular risk (HR, 1.13;95% CI, 1.05-1.22). People reaching the apoB but not the LDL-C target had a slightly higher HR of 1.18 (95% CI, 0.96-1.45), but this estimate did not reach statistical significance due to a low number of events.
机译:博士和琼斯博士同意我们达到其LDL-C目标但不是他们的非HDL-C目标的个人处于增加的心血管风险,而相反则不是这种情况。 他们要求另外2分析。 达到70 mg / dL的LDL-C靶的人,但不是100mg / dl的非HDL-C靶没有增加心血管风险增加(HR,1.05; 95%CI,0.88-1.26),而这两种 目标。 对于到达非HDL-C但不是LDL-C靶(HR,0.93; 95%CI,0.82-1.05)的那些,这也是如此。 使用Contois等人的建议使用100mg / dL的LDL-C靶标的LDL-C靶和80mg / dl的APOB靶结果产生略微不同。 到达LDL-C但不是APOB靶标的人数增加了心血管风险增加(HR,1.13; 95%CI,1.05-1.22)。 人们到达Apob但不是LDL-C目标的HR略高于1.18(95%CI,0.96-1.45),但由于事件数量较少,这种估计没有达到统计学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号